Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period
- PMID: 34854892
- PMCID: PMC8640948
- DOI: 10.1001/jamaophthalmol.2021.5052
Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period
Abstract
Importance: Despite the increasing prevalence of type 2 diabetes (T2D) diagnosed in childhood, little is known about the natural history of ocular sequelae in youth-onset T2D compared with type 1 diabetes (T1D).
Objective: To assess the risk of developing diabetes-associated ocular complications among youth diagnosed with diabetes.
Design, setting, and participants: This retrospective, population-based medical record review included all residents of Olmsted County, Minnesota (95.7% White in 1990), diagnosed with diabetes at younger than 22 years (hereinafter referred to as children) from January 1, 1970, through December 31, 2019.
Main outcomes and measures: Risk of developing ocular complications over time.
Results: Among 1362 individuals with a diagnostic code of diabetes, medical record reviews confirmed a diagnosis of T1D or T2D in 606 children, of whom 525 (86.6%) underwent at least 1 eye examination (mean [SD] age at diabetes diagnosis, 12.1 [5.4] years; 264 [50.3%] male). Diabetes-associated ocular complications occurred in 147 of the 461 children (31.2%) with T1D and in 17 of the 64 children (26.6%) with T2D. The hazard ratio illustrating the risk between T2D and T1D rates was 1.88 (95% CI, 1.13-3.12; P = .02) for developing any diabetic retinopathy (nonproliferative or greater), 2.33 (95% CI, 0.99-5.50; P = .048) for proliferative diabetic retinopathy, 1.49 (95% CI, 0.46-4.89; P = .50) for diabetic macular edema, 2.43 (95% CI, 0.54-11.07; P = .24) for a visually significant cataract, and 4.06 (95% CI, 1.34-12.33; P = .007) for requiring pars plana vitrectomy by 15 years after the diagnosis of diabetes.
Conclusions and relevance: Diabetic retinopathy, proliferative diabetic retinopathy, and the need for pars plana vitrectomy occurred within a shorter diabetes duration for children with T2D compared with T1D in this population-based cohort. Children with T2D had almost twice the risk of developing retinopathy compared with those with T1D. These findings suggest that to prevent serious ocular complications, children with T2D may require ophthalmoscopic evaluations at least as frequently as or more frequently than children with T1D.
Conflict of interest statement
Comment in
-
The Growing Need to Understand Diabetic Retinopathy Outcomes in Youth.JAMA Ophthalmol. 2022 Jan 1;140(1):57-58. doi: 10.1001/jamaophthalmol.2021.5050. JAMA Ophthalmol. 2022. PMID: 34854913 No abstract available.
Comment on
-
The Growing Need to Understand Diabetic Retinopathy Outcomes in Youth.JAMA Ophthalmol. 2022 Jan 1;140(1):57-58. doi: 10.1001/jamaophthalmol.2021.5050. JAMA Ophthalmol. 2022. PMID: 34854913 No abstract available.
Similar articles
-
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Mar 1;6(3):e231887. doi: 10.1001/jamanetworkopen.2023.1887. JAMA Netw Open. 2023. PMID: 36930156 Free PMC article.
-
Incidence and sex differences of diabetes among youth: a 50-year population-based cohort study.Acta Diabetol. 2024 Dec;61(12):1511-1516. doi: 10.1007/s00592-024-02314-0. Epub 2024 Jun 7. Acta Diabetol. 2024. PMID: 38849657
-
Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis.JAMA Ophthalmol. 2022 May 1;140(5):486-494. doi: 10.1001/jamaophthalmol.2022.0050. JAMA Ophthalmol. 2022. PMID: 35357410 Free PMC article.
-
Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.Pediatr Diabetes. 2020 Aug;21(5):856-862. doi: 10.1111/pedi.13037. Epub 2020 May 31. Pediatr Diabetes. 2020. PMID: 32410329 Free PMC article.
-
Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.JAMA Ophthalmol. 2020 Oct 1;138(10):1063-1069. doi: 10.1001/jamaophthalmol.2020.3190. JAMA Ophthalmol. 2020. PMID: 32880616 Free PMC article.
Cited by
-
The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003-2016.Cardiovasc Diabetol. 2023 Sep 29;22(1):267. doi: 10.1186/s12933-023-01998-y. Cardiovasc Diabetol. 2023. PMID: 37775767 Free PMC article.
-
Major adverse events in youth-onset type 1 and type 2 diabetes: The SEARCH and TODAY studies.Diabetes Res Clin Pract. 2024 Apr;210:111606. doi: 10.1016/j.diabres.2024.111606. Epub 2024 Mar 15. Diabetes Res Clin Pract. 2024. PMID: 38493952 Free PMC article.
-
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Mar 1;6(3):e231887. doi: 10.1001/jamanetworkopen.2023.1887. JAMA Netw Open. 2023. PMID: 36930156 Free PMC article.
-
Geriatric Nutrition Risk Index as a predictor of cardiovascular and all-cause mortality in older Americans with diabetes.Diabetol Metab Syndr. 2023 May 2;15(1):89. doi: 10.1186/s13098-023-01060-7. Diabetol Metab Syndr. 2023. PMID: 37127636 Free PMC article.
-
The Neutrophil Percentage-to-Albumin Ratio as a Biomarker for All-Cause and Diabetes-Cause Mortality Among Diabetes Patients: Evidence From the NHANES 1988-2018.J Clin Lab Anal. 2024 Nov;38(21):e25110. doi: 10.1002/jcla.25110. Epub 2024 Oct 10. J Clin Lab Anal. 2024. PMID: 39387531 Free PMC article.
References
-
- Forlenza GP, Stewart MW. Diabetic retinopathy in children. Pediatr Endocrinol Rev. 2012;10(2):217-226. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous